Plus Therapeutics, PPS expand partnership for drug production
The injectable radiotherapy rhenium (186Re) obisbemeda has the potential to minimise risks and enhance outcomes for CNS cancer patients. Credit: fernando zhiminaicela from Pixabay. Plus
Srivani Venna
May 2, 2023